Access to anti-retroviral drugs, male in Ecuador

Ecuador: Access to anti-retroviral drugs, male was 87.0% in 2024. ◆ Volatile

Latest (2024)
87.0%
Change on year
up 2.4%
World rank
27th
of 141 countries
All-time high
87.0%
in 2024
All-time low
1.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Ecuador, 2000–2024

0204060802000201220242000: 1 %2001: 1 %2002: 1 %2003: 1 %2004: 3 %2005: 4 %2006: 5 %2007: 8 %2008: 12 %2009: 16 %2010: 21 %2011: 26 %2012: 25 %2013: 25 %2014: 28 %2015: 34 %2016: 44 %2017: 50 %2018: 57 %2019: 69 %2020: 73 %2021: 73 %2022: 81 %2023: 85 %2024: 87 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in Ecuador is 87.0%, measured in 2024. That is the highest value across all 25 years on record.

That represents a change of up 2.4% on the previous year and up 210.7% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Ecuador peaked at 87.0% in 2024 and was at its lowest, 1.0%, in 2000.

That places Ecuador 27th out of 141 countries with data for 2024, putting it in the top quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Ecuador, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Ecuador, 2000 to 2024.
Year % Change
2000 1.0%
2001 1.0% +0.0%
2002 1.0% +0.0%
2003 1.0% +0.0%
2004 3.0% +200.0%
2005 4.0% +33.3%
2006 5.0% +25.0%
2007 8.0% +60.0%
2008 12.0% +50.0%
2009 16.0% +33.3%
2010 21.0% +31.2%
2011 26.0% +23.8%
2012 25.0% -3.8%
2013 25.0% +0.0%
2014 28.0% +12.0%
2015 34.0% +21.4%
2016 44.0% +29.4%
2017 50.0% +13.6%
2018 57.0% +14.0%
2019 69.0% +21.1%
2020 73.0% +5.8%
2021 73.0% +0.0%
2022 81.0% +11.0%
2023 85.0% +4.9%
2024 87.0% +2.4%

Averages by decade

DecadeAverage LowestHighest Years
2000s 5.2% 1.0% 16.0% 10
2010s 37.9% 21.0% 69.0% 10
2020s 79.8% 73.0% 87.0% 5

Countries ranked near Ecuador

  1. 27 Haiti 87.0% compare
  2. 27 Slovenia 87.0% compare
  3. 30 Liberia 86.0% compare
  4. 30 Singapore 86.0% compare
  5. 30 Thailand 86.0% compare
  6. 30 Togo 86.0% compare

See the full ranking of 160 places →

More gender data for Ecuador

All data for Ecuador →

Frequently asked questions

What is access to anti-retroviral drugs, male in Ecuador?
Access to anti-retroviral drugs, male in Ecuador was 87.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Ecuador?
The highest recorded value was 87.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Ecuador?
The lowest recorded value was 1.0% in 2000.
How does Ecuador rank for access to anti-retroviral drugs, male?
Ecuador ranks 27th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Ecuador?
Over the last ten years it is up 210.7%. The long-run trend across the full record is volatile.
Where does this Ecuador data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Ecuador. Statizoid, drawing on UNAIDS estimates. Retrieved 07 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/ecuador/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/ecuador/">Access to anti-retroviral drugs, male in Ecuador</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.